Joseph Gilliam
Präsident bei GLAUKOS CORPORATION
Vermögen: 15 Mio $ am 31.12.2024
Aktuelles zu Joseph Gilliam
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GLAUKOS CORPORATION | Health Technology |
JPMORGAN CHASE & CO. | Finance |
Private Unternehmen | 2 |
---|---|
Avedro, Inc.
![]() Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Caris Life Sciences, LLC
![]() Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Health Services |
Ausbildung von Joseph Gilliam
Kelley School of Business | Undergraduate Degree |
- Börse
- Insiders
- Joseph Gilliam
- Nachrichten